Literature DB >> 11534540

Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in polydrug use.

F Leri1, J Stewart.   

Abstract

The authors investigated several features of polydrug use in rats. Heroin and cocaine were self-administered following responses on different levers, with only 1 drug and 1 lever available on alternate days of training. Four doses of each drug (heroin: 25, 50, 100, and 200 microg/kg/infusion; cocaine: 0.25, 0.5, 1, and 2 mg/kg/infusion) were tested, and each rat was exposed to a single dose combination. Rats readily developed drug-specific and dose-related responding. During extinction, rats displayed a significant bias for responding on the cocaine- associated lever. Priming injections of either cocaine (20 mg/kg) or heroin (0.25 mg/kg) reinstated responding that was selective for the lever previously associated with each drug. These results suggest that in this type of polydrug use, drugs have the capacity to activate drug-seeking behavior selectively oriented toward stimuli previously associated with their administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534540     DOI: 10.1037//1064-1297.9.3.297

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  24 in total

1.  Lesions of medial prefrontal cortex disrupt the acquisition but not the expression of goal-directed learning.

Authors:  Sean B Ostlund; Bernard W Balleine
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

2.  Selective reinstatement of instrumental performance depends on the discriminative stimulus properties of the mediating outcome.

Authors:  Sean B Ostlund; Bernard W Balline
Journal:  Learn Behav       Date:  2007-02       Impact factor: 1.986

3.  Dopamine receptor blockade attenuates the general incentive motivational effects of noncontingently delivered rewards and reward-paired cues without affecting their ability to bias action selection.

Authors:  Sean B Ostlund; Nigel T Maidment
Journal:  Neuropsychopharmacology       Date:  2011-09-14       Impact factor: 7.853

4.  Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting.

Authors:  Christian Montanari; Emiliana Stendardo; Maria Teresa De Luca; Maria Meringolo; Laura Contu; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2015-02-10       Impact factor: 4.530

5.  The impact of cocaine and heroin drug history on motivation and cue sensitivity in a rat model of polydrug abuse.

Authors:  Elizabeth A Crummy; Elizabeth A Donckels; Britahny M Baskin; Brandon S Bentzley; Susan M Ferguson
Journal:  Psychopharmacology (Berl)       Date:  2019-08-28       Impact factor: 4.530

6.  Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice.

Authors:  Jia Zhan; Chloe J Jordan; Guo-Hua Bi; Xiang-Hu He; Eliot L Gardner; Yan-Lin Wang; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2018-08-20       Impact factor: 5.250

7.  Perhaps More Consideration of Pavlovian-Operant Interaction May Improve the Clinical Efficacy of Behaviorally Based Drug Treatment Programs.

Authors:  Joseph R Troisi
Journal:  Psychol Rec       Date:  2013

8.  The effects of oral micronized progesterone on smoked cocaine self-administration in women.

Authors:  Stephanie Collins Reed; Suzette M Evans; Gillinder Bedi; Eric Rubin; Richard W Foltin
Journal:  Horm Behav       Date:  2010-12-28       Impact factor: 3.587

9.  Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats.

Authors:  Justin J Anker; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2009-12-02       Impact factor: 4.530

10.  Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat.

Authors:  Robert J Hayes; Stanislav R Vorel; Jordan Spector; Xinhe Liu; Eliot L Gardner
Journal:  Psychopharmacology (Berl)       Date:  2003-01-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.